Euro VC Ysios Capital Seeks $134 Million For Life Sciences Fund

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ysios Capital launches fundraising efforts to pad its BioFund II lifesciences investment pool, planning on supporting up to 15 emerging companies in medtech, diagnostics and pharmaceuticals. European venture capital firm Ysios Capital is looking to raise some $137.8 million (€100 million) in support of its lifesciences investment activities. Ysios plans to use funds from the investment pool, which the company calls its BioFund II, to support up to 15 lifesciences companies with disruptive potential.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC